| Literature DB >> 35041512 |
Muneyoshi Kimura1, Yuki Asano-Mori2, Takashi Sakoh1, Masahiro Abe3, Keigo Ueno3, Yasutaka Hoshino3, Shigeki Nakamura3,4, Takashi Umeyama3, Satoshi Yamagoe3, Yoshitsugu Miyazaki3, Masaru Baba1, Chikako Okada1, Sho Ogura1, Takashi Mitsuki5, Kyosuke Yamaguchi2, Mitsuhiro Yuasa2, Daisuke Kaji2, Kosei Kageyama2, Aya Nishida5, Yuki Taya2, Kazuya Ishiwata5, Shinsuke Takagi2, Hisashi Yamamoto2, Go Yamamoto2, Naoyuki Uchida2,6, Atsushi Wake5,6, Shuichi Taniguchi2,6, Hideki Araoka1,6.
Abstract
Limited data are available on breakthrough fungemia, defined as fungemia that develops on administration of antifungal agents, in patients with hematological disorders. We reviewed the medical and microbiological records of adult patients with hematological diseases who had breakthrough fungemia between January 2008 and July 2019 at Toranomon Hospital and Toranomon Hospital Kajigaya in Japan. A total of 121 cases of breakthrough fungemia were identified. Of the 121 involved patients, 83, 11, 5, and 22 were receiving micafungin, voriconazole, itraconazole, and liposomal amphotericin B, respectively, when the breakthrough occurred. Of the 121 causative breakthrough fungal strains, 96 were Candida species, and the rest were 13 cases of Trichosporon species, 7 of Fusarium species, 2 of Rhodotorula mucilaginosa, and 1 each of Cryptococcus neoformans, Exophiala dermatitidis, and Magnusiomyces capitatus. The crude 14-day mortality rate of breakthrough fungemia was 36%. Significant independent factors associated with the crude 14-day mortality rate were age of ≥60 years (P = 0.011), chronic renal failure (P = 0.0087), septic shock (P < 0.0001), steroid administration (P = 0.0085), and liposomal amphotericin B breakthrough fungemia (P = 0.0011). An absolute neutrophil count of >500/μL was significantly more common in candidemia in the multivariate analysis (P = 0.0065), neutropenia and nonallogeneic hematopoietic stem cell transplants were significantly more common in Trichosporon fungemia (P = 0.036 and P = 0.033, respectively), and voriconazole breakthrough fungemia and neutropenia were significantly more common in Fusarium fungemia (P = 0.016 and P = 0.016, respectively). The epidemiological and clinical characteristics of breakthrough fungemia of patients with hematological disorders were demonstrated. Some useful factors to predict candidemia, Trichosporon fungemia, and Fusarium fungemia were identified.Entities:
Keywords: Exophiala dermatitidis; Fusarium dimerum species complex; Magnusiomyces capitatus; Trichosporon asahii; breakthrough fungemia; hematological malignancy; liposomal amphotericin B breakthrough
Mesh:
Substances:
Year: 2022 PMID: 35041512 PMCID: PMC8923220 DOI: 10.1128/AAC.02081-21
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.938